https://news.medxy.ai/ja/%e9%bc%bb%e5%89%af%e9%bc%bb%e8%85%94%e8%85%ab%e7%98%a4%e3%82%92%e3%81%a9%e3%81%86%e8%a9%95%e4%be%a1%e3%81%99%e3%82%8b%e3%81%8b%ef%bc%9a%e5%ad%a6%e9%9a%9b%e7%9a%84%e3%82%b3%e3%83%b3%e3%82%bb%e3%83%b3/Medxy AIja2026-07-20T11:59:11-07:00鼻副鼻腔腫瘤をどう評価するか：学際的コンセンサスが示す重要ポイント https://news.medxy.ai/vi/danh-gia-khoi-vung-mui-xoang-nhu-the-nao-nhung-khuyen-nghi-trong-tam-tu-dong-thuan-da-chuyen-nganh/Medxy AIvi2026-07-20T11:58:38-07:00Đánh giá khối vùng mũi-xoang như thế nào: Những khuyến nghị trọng tâm từ đồng thuận đa chuyên ngành https://news.medxy.ai/zh/%e5%a6%82%e4%bd%95%e8%af%84%e4%bc%b0%e9%bc%bb%e7%aa%a6%e9%bc%bb%e8%85%94%e5%8d%a0%e4%bd%8d%ef%bc%9a%e5%a4%9a%e5%ad%a6%e7%a7%91%e5%85%b1%e8%af%86%e7%9a%84%e5%85%b3%e9%94%ae%e5%bb%ba%e8%ae%ae/Medxy AIzh2026-07-20T11:58:07-07:00如何评估鼻窦鼻腔占位：多学科共识的关键建议 https://news.medxy.ai/how-to-evaluate-a-sinonasal-mass-key-recommendations-from-a-multidisciplinary-consensus/Medxy AIen2026-07-20T11:56:41-07:00How to Evaluate a Sinonasal Mass: Key Recommendations from a Multidisciplinary Consensus https://news.medxy.ai/zh/outcomes-of-endoscopic-choanal-atresia-repair/Medxy AIzh2026-07-20T11:54:54-07:00无支架内镜修复先天性后鼻孔闭锁的长期结局：一项10年儿科队列研究 https://news.medxy.ai/ja/outcomes-of-endoscopic-choanal-atresia-repair-using-mucoperiosteal-flaps/Medxy AIja2026-07-20T11:54:36-07:00ステント非留置のムコペリオステアル弁による後鼻孔閉鎖内視鏡修復の長期成績：小児10年コホートからの知見 https://news.medxy.ai/vi/long-term-outcomes-of-endoscopic-choanal-atresia-repair-using-mucoperiosteal-flaps-without-stenting/Medxy AIvi2026-07-20T11:54:13-07:00Kết quả dài hạn của sửa chữa nội soi tịt cửa mũi sau bằng vạt niêm mạc–màng xương không đặt stent: kinh nghiệm 10 năm ở trẻ em https://news.medxy.ai/long-term-outcomes-of-endoscopic-choanal-atresia-repair-using-mucoperiosteal-flaps-without-stenting-insights-from-a-10-year-pediatric-cohort/Medxy AIen2026-07-20T11:53:27-07:00Long-Term Outcomes of Endoscopic Choanal Atresia Repair Using Mucoperiosteal Flaps Without Stenting: Insights from a 10-Year Pediatric Cohort https://news.medxy.ai/zh/quality-of-life-in-malignant-bowel-obstruction/Medxy AIzh2026-07-20T11:46:57-07:00减压性胃造口管在恶性肠梗阻中的生活质量获益：一项回顾性队列研究 https://news.medxy.ai/ja/quality-of-life-with-venting-gastrostomy-tubes-in-malignant-bowel-obstruction/Medxy AIja2026-07-20T11:46:42-07:00悪性腸閉塞に対する venting gastrostomy tube で生活の質を改善する：後ろ向きコホート研究からの示唆 https://news.medxy.ai/vi/improving-quality-of-life-with-venting-gastrostomy-tubes-in-malignant-bowel-obstruction/Medxy AIvi2026-07-20T11:46:26-07:00Nâng cao chất lượng sống bằng ống mở thông dạ dày dẫn lưu trong tắc ruột do ung thư: phát hiện từ một nghiên cứu đoàn hệ hồi cứu https://news.medxy.ai/improving-quality-of-life-with-venting-gastrostomy-tubes-in-malignant-bowel-obstruction-insights-from-a-retrospective-cohort-study/Medxy AIen2026-07-20T11:45:52-07:00Improving Quality of Life with Venting Gastrostomy Tubes in Malignant Bowel Obstruction: Insights from a Retrospective Cohort Study https://news.medxy.ai/zh/toripalimab-enhances-surgical-outcomes-and-survival-in-stage-iii-resectable-nsclc/Medxy AIzh2026-07-20T11:36:05-07:00围手术期特瑞普利单抗联合化疗可显著提高Ⅲ期可切除非小细胞肺癌手术率及生存 https://news.medxy.ai/ja/perioperative-toripalimab-enhances-surgical-outcomes-and-survival-in-stage-iii-resectable-nsclc-2/Medxy AIja2026-07-20T11:35:46-07:00切除可能III期NSCLCに対する周術期トリパリマブが手術成績と生存を改善：Neotorch試験の知見 https://news.medxy.ai/vi/perioperative-toripalimab-enhances-surgical-outcomes-and-survival-in-stage-iii-resectable-nsclc/Medxy AIvi2026-07-20T11:35:24-07:00Toripalimab chu phẫu giúp cải thiện kết quả phẫu thuật và sống còn ở NSCLC giai đoạn III có thể cắt bỏ: Góc nhìn từ nghiên cứu Neotorch https://news.medxy.ai/perioperative-toripalimab-enhances-surgical-outcomes-and-survival-in-stage-iii-resectable-nsclc-insights-from-the-neotorch-trial/Medxy AIen2026-07-20T11:34:32-07:00Perioperative Toripalimab Enhances Surgical Outcomes and Survival in Stage III Resectable NSCLC: Insights from the Neotorch Trial https://news.medxy.ai/health-insurance-instability-following-firearm-injury-a-matched-cohort-case-report/Medxy AIen2026-07-20T11:30:08-07:00Health Insurance Instability Following Firearm Injury: A Matched Cohort Case Report https://news.medxy.ai/unraveling-failure-to-rescue-in-major-gynecologic-cancer-surgery-insights-from-a-nsqip-analysis/Medxy AIen2026-07-20T11:27:54-07:00Unraveling Failure to Rescue in Major Gynecologic Cancer Surgery: Insights from a NSQIP Analysis https://news.medxy.ai/zh/decoding-placental-pathology-risks-in-dichorionic-twins-in-ultrasound-phenotypes/Medxy AIzh2026-07-20T11:17:50-07:00双绒毛膜双胎胎盘病理风险如何分层？超声表型揭示胎儿生长受损的不同风险 https://news.medxy.ai/ja/placental-pathology-risks-in-dichorionic-twins/Medxy AIja2026-07-20T11:17:29-07:00二絨毛膜双胎の胎盤病理リスクを読み解く：胎児発育障害の超音波表現型 https://news.medxy.ai/vi/placental-pathology-risks-in-dichorionic-twins-of-fetal-growth-impairment/Medxy AIvi2026-07-20T11:16:58-07:00Giải mã nguy cơ bệnh lý nhau thai ở song thai hai bánh nhau: Các kiểu hình siêu âm của suy giảm tăng trưởng thai https://news.medxy.ai/decoding-placental-pathology-risks-in-dichorionic-twins-ultrasound-phenotypes-of-fetal-growth-impairment/Medxy AIen2026-07-20T11:16:09-07:00Decoding Placental Pathology Risks in Dichorionic Twins: Ultrasound Phenotypes of Fetal Growth Impairment https://news.medxy.ai/zh/long-term-benefits-of-hormone-therapy-in-young-cervical-cancer/Medxy AIzh2026-07-20T11:02:54-07:00年轻宫颈癌幸存者接受放化疗后激素治疗的安全性及长期获益 https://news.medxy.ai/ja/long-term-benefits-of-hormone-therapy-after-chemoradiation-in-young-cervical-cancer/Medxy AIja2026-07-20T11:02:35-07:00化学放射線療法後のホルモン療法：若年子宮頸癌サバイバーにおける安全性と長期利益 https://news.medxy.ai/vi/safety-and-long-term-benefits-of-hormone-therapy-after-chemoradiation-in-young-cervical-cancer/Medxy AIvi2026-07-20T11:02:12-07:00Liệu pháp hormone sau hóa xạ trị: an toàn và lợi ích dài hạn ở người sống sót trẻ sau ung thư cổ tử cung https://news.medxy.ai/safety-and-long-term-benefits-of-hormone-therapy-after-chemoradiation-in-young-cervical-cancer-survivors/Medxy AIen2026-07-20T11:01:17-07:00Safety and Long-Term Benefits of Hormone Therapy After Chemoradiation in Young Cervical Cancer Survivors https://news.medxy.ai/ja/neurodevelopmental-outcomes-in-late-preterm-hypoglycemia/Medxy AIja2026-07-20T10:59:51-07:00後期早産児の低血糖後にみられる神経発達転帰 https://news.medxy.ai/vi/child-neurodevelopmental-outcomes-in-late-preterm-hypoglycemia/Medxy AIvi2026-07-20T10:59:31-07:00Hạ đường huyết ở trẻ sinh non muộn và kết cục phát triển thần kinh: phát hiện đáng yên tâm https://news.medxy.ai/child-neurodevelopmental-outcomes-after-late-preterm-hypoglycemia/Medxy AIen2026-07-20T10:58:40-07:00Child Neurodevelopmental Outcomes After Late Preterm Hypoglycemia https://news.medxy.ai/ja/decompensated-cirrhosis-in-metabolic-dysfunction-related-steatotic-liver-disease/Medxy AIja2026-07-20T10:55:07-07:00MASLD・MetALD関連非代償性肝硬変を再代償化へ導くには：禁酒、減量、心代謝管理の重要性 https://news.medxy.ai/vi/decompensated-cirrhosis-in-mdsld/Medxy AIvi2026-07-20T10:54:44-07:00Tái bù xơ gan mất bù trong bệnh gan nhiễm mỡ liên quan rối loạn chuyển hóa: Vai trò của kiêng rượu, giảm cân và kiểm soát tim chuyển hóa https://news.medxy.ai/zh/il-17-ngal-nets-itga5-axis-overcome-in-pancreatic-cancer/Medxy AIzh2026-07-20T10:14:33-07:00靶向IL-17/NGAL/NETs/ITGA5轴：克服胰腺癌免疫抑制与成纤维细胞重编程的新策略 https://news.medxy.ai/vi/targeting-the-il-17-ngal-nets-itga5-axis-in-pancreatic-cancer/Medxy AIvi2026-07-20T10:13:47-07:00Nhắm trúng trục IL-17/NGAL/NETs/ITGA5: Chiến lược mới để vượt qua ức chế miễn dịch và tái lập trình nguyên bào sợi trong ung thư tụy https://news.medxy.ai/targeting-the-il-17-ngal-nets-itga5-axis-a-novel-strategy-to-overcome-immunosuppression-and-fibroblast-reprogramming-in-pancreatic-cancer/Medxy AIen2026-07-20T10:12:13-07:00Targeting the IL-17/NGAL/NETs/ITGA5 Axis: A Novel Strategy to Overcome Immunosuppression and Fibroblast Reprogramming in Pancreatic Cancer https://news.medxy.ai/dr5-ligase-3-feedback-loop-unlocking-the-immunogenicity-of-mismatch-repair-deficient-colorectal-cancer/Medxy AIen2026-07-20T10:08:18-07:00DR5/Ligase 3 Feedback Loop: Unlocking the Immunogenicity of Mismatch Repair-Deficient Colorectal Cancer https://news.medxy.ai/zh/brain-perivascular-space-morphometry-on-microvascular-traits-and-neuropsychiatric-factors/Medxy AIzh2026-07-20T08:49:01-07:00脑周血管间隙形态计量学揭示家族性微血管特征与神经精神影响 https://news.medxy.ai/ja/microvascular-traits-and-neuropsychiatric-factors-in-brain-perivascular-space-morphometry/Medxy AIja2026-07-20T08:48:40-07:00脳周囲血管腔の形態から見えた家族性微小血管特性と神経精神医学的因子 https://news.medxy.ai/vi/familial-microvascular-traits-and-neuropsychiatric-factors-in-brain-perivascular-space-morphometry/Medxy AIvi2026-07-20T08:48:18-07:00Đặc điểm vi mạch gia đình và yếu tố tâm thần kinh qua hình thái các khoang quanh mạch máu não https://news.medxy.ai/familial-microvascular-traits-and-neuropsychiatric-factors-reflected-in-brain-perivascular-space-morphometry/Medxy AIen2026-07-20T08:46:35-07:00Familial Microvascular Traits and Neuropsychiatric Factors Reflected in Brain Perivascular Space Morphometry https://news.medxy.ai/zh/effectiveness-and-safety-of-emerging-myasthenia-gravis-therapies/Medxy AIzh2026-07-20T08:36:01-07:00新兴重症肌无力治疗的疗效与安全性比较：来自 Bayesian 网络荟萃分析的启示 https://news.medxy.ai/vi/comparative-effectiveness-and-safety-of-emerging-myasthenia-gravis-therapies/Medxy AIvi2026-07-20T08:35:06-07:00Hiệu quả và độ an toàn so sánh của các liệu pháp mới trong nhược cơ: Góc nhìn từ phân tích tổng hợp mạng Bayesian https://news.medxy.ai/comparative-effectiveness-and-safety-of-emerging-myasthenia-gravis-therapies-insights-from-a-bayesian-network-meta-analysis/Medxy AIen2026-07-20T08:33:39-07:00Comparative Effectiveness and Safety of Emerging Myasthenia Gravis Therapies: Insights From a Bayesian Network Meta-Analysis https://news.medxy.ai/ja/participant-reported-outcomes-residual-beta-cell-function-in-youth-with-newly-diagnosed-t1dm/Medxy AIja2026-07-20T08:32:42-07:00新規診断1型糖尿病の若年者における患者報告アウトカム、残存β細胞機能、代謝指標の関連 https://news.medxy.ai/vi/participant-reported-outcomes-residual-beta-cell-function-and-metabolic-parameters-in-youth-with-newly-diagnosed-t1dm/Medxy AIvi2026-07-20T08:32:21-07:00Mối liên quan giữa kết cục do người tham gia báo cáo, chức năng tế bào beta còn lại và các chỉ số chuyển hóa ở trẻ em và thanh thiếu niên mới được chẩn đoán đái tháo đường type 1 https://news.medxy.ai/relationship-between-participant-reported-outcomes-residual-beta-cell-function-and-metabolic-parameters-in-youth-with-newly-diagnosed-type-1-diabetes/Medxy AIen2026-07-20T08:31:10-07:00Relationship between Participant-Reported Outcomes, Residual Beta Cell Function, and Metabolic Parameters in Youth with Newly Diagnosed Type 1 Diabetes https://news.medxy.ai/zh/anti-zscan1-antibodies-in-diagnosis-and-management-for-rohhad-net-syndrome/Medxy AIzh2026-07-19T10:28:30-07:00解读ROHHAD-NET综合征：临床要点及抗ZSCAN1抗体在诊断与管理中的作用 https://news.medxy.ai/ja/rohhad-net-syndrome-and-anti-zscan1-antibodies/Medxy AIja2026-07-19T10:28:13-07:00ROHHAD-NET症候群を読み解く：臨床的示唆と診断・管理におけるanti-ZSCAN1抗体の役割 https://news.medxy.ai/vi/rohhad-net-syndrome-and-anti-zscan1-antibodies-in-diagnosis-and-management/Medxy AIvi2026-07-19T10:27:54-07:00Giải mã hội chứng ROHHAD-NET: Thông tin lâm sàng và vai trò của kháng thể anti-ZSCAN1 trong chẩn đoán và xử trí https://news.medxy.ai/unraveling-rohhad-net-syndrome-clinical-insights-and-the-role-of-anti-zscan1-antibodies-in-diagnosis-and-management/Medxy AIen2026-07-19T10:27:13-07:00Unraveling ROHHAD-NET Syndrome: Clinical Insights and the Role of Anti-ZSCAN1 Antibodies in Diagnosis and Management https://news.medxy.ai/zh/igg-n-glycosylation-for-diabetic-nephropathy-in-type-2-diabetes/Medxy AIzh2026-07-19T09:05:26-07:00IgG N-糖基化特征：2型糖尿病患者糖尿病肾病的潜在预测生物标志物——基于汇总前瞻性队列分析的研究洞见 https://news.medxy.ai/ja/igg-n-glycosylation-profiles-for-diabetic-nephropathy-in-type-2-diabetes/Medxy AIja2026-07-19T09:05:00-07:002型糖尿病における糖尿病性腎症の予測バイオマーカーとしての IgG N-グリコシル化プロファイル：統合前向きコホート解析からの知見 https://news.medxy.ai/vi/igg-n-glycosylation-profiles-as-predictive-biomarkers-for-diabetic-nephropathy-in-type-2-diabetes/Medxy AIvi2026-07-19T09:04:42-07:00Hồ sơ N-glycosyl hóa IgG có thể dự báo bệnh thận do đái tháo đường ở đái tháo đường type 2: phát hiện từ phân tích gộp tiền cứu đa đoàn hệ https://news.medxy.ai/igg-n-glycosylation-profiles-as-predictive-biomarkers-for-diabetic-nephropathy-in-type-2-diabetes-insights-from-a-pooled-prospective-cohort-analysis/Medxy AIen2026-07-19T09:03:18-07:00IgG N-Glycosylation Profiles as Predictive Biomarkers for Diabetic Nephropathy in Type 2 Diabetes: Insights from a Pooled Prospective Cohort Analysis https://news.medxy.ai/ja/development-and-validation-of-a-simplified-martin-hopkins-ldl-c-equation-using-machine-learning-3/Medxy AIja2026-07-18T20:12:48-07:00機械学習で簡略化したMartin-Hopkins LDL-C推定式の開発と検証 https://news.medxy.ai/vi/development-and-validation-of-a-simplified-martin-hopkins-ldl-c-equation-using-machine-learning-2/Medxy AIvi2026-07-18T20:12:32-07:00Ước tính LDL-C đơn giản hóa bằng học máy: phát triển và xác thực công thức Martin-Hopkins cải tiến https://news.medxy.ai/development-and-validation-of-a-simplified-martin-hopkins-ldl-c-equation-using-machine-learning/Medxy AIen2026-07-18T20:11:47-07:00Development and Validation of a Simplified Martin-Hopkins LDL-C Equation Using Machine Learning https://news.medxy.ai/peripheral-artery-disease-emerging-advances-in-medical-therapy-to-reduce-cardiovascular-and-limb-risks/Medxy AIen2026-07-18T20:09:10-07:00Peripheral Artery Disease: Emerging Advances in Medical Therapy to Reduce Cardiovascular and Limb Risks https://news.medxy.ai/zh/myocardial-scar-detection-ai-powered-contrast-mri/Medxy AIzh2026-07-18T13:01:54-07:00AI赋能的无对比剂MRI：虚拟原生增强推动心肌瘢痕检出革新 https://news.medxy.ai/ja/myocardial-scar-detection-ai-powered-contrast-free-mri/Medxy AIja2026-07-18T13:01:35-07:00AIで心筋瘢痕を見抜く：Virtual Native Enhancementが切り開く無造影MRIの新時代 https://news.medxy.ai/vi/myocardial-scar-detection-ai-powered-contrast-free-mri-via-virtual-native-enhancement/Medxy AIvi2026-07-18T13:01:13-07:00AI mở ra hướng mới trong phát hiện sẹo cơ tim: MRI không cần thuốc cản quang với Virtual Native Enhancement https://news.medxy.ai/revolutionizing-myocardial-scar-detection-ai-powered-contrast-free-mri-via-virtual-native-enhancement/Medxy AIen2026-07-18T13:00:34-07:00Revolutionizing Myocardial Scar Detection: AI-Powered Contrast-Free MRI via Virtual Native Enhancement https://news.medxy.ai/ja/out-of-hospital-cardiac-arrest-of-etco2-with-rosc/Medxy AIja2026-07-18T12:59:42-07:00院外心停止蘇生におけるEtCO2の軌跡解析：ROSC予測に有用な指標 https://news.medxy.ai/vi/resuscitation-from-out-of-hospital-cardiac-arrest-of-etco2-with-rosc/Medxy AIvi2026-07-18T12:59:20-07:00Ngừng tim ngoài bệnh viện: EtCO2 có thể dự báo ROSC đáng tin cậy như thế nào https://news.medxy.ai/resuscitation-from-out-of-hospital-cardiac-arrest-reliable-association-of-etco2-with-rosc/Medxy AIen2026-07-18T12:58:29-07:00Resuscitation From Out-of-Hospital Cardiac Arrest: Reliable Association of EtCO2 with ROSC https://news.medxy.ai/zh/gender-affirming-surgery-nipple-punch-grafts-combined-with-3d-areola-tattooing-for-superior-aesthetic-outcomes/Medxy AIzh2026-07-18T12:54:51-07:00性别肯定手术再进阶：乳头穿孔移植联合 3D 乳晕纹身，带来更优美学结局 https://news.medxy.ai/ja/gender-affirming-surgery-nipple-punch-grafts-combined-with-3d-areola-tattooing/Medxy AIja2026-07-18T12:54:34-07:00ジェンダー肯定的乳房手術をさらに洗練：乳頭パンチ移植と3D乳輪タトゥーでより自然な仕上がりへ https://news.medxy.ai/advancing-gender-affirming-surgery-nipple-punch-grafts-combined-with-3d-areola-tattooing-for-superior-aesthetic-outcomes/Medxy AIen2026-07-18T12:53:37-07:00Advancing Gender-Affirming Surgery: Nipple Punch Grafts Combined with 3D Areola Tattooing for Superior Aesthetic Outcomes https://news.medxy.ai/zh/surgical-site-infection-in-implant-based-breast-reconstruction/Medxy AIzh2026-07-18T12:48:25-07:00五年证实：GAPS 方案可显著降低植入物乳房重建术后感染风险 https://news.medxy.ai/vi/reducing-surgical-site-infection-in-implant-based-breast-reconstruction/Medxy AIvi2026-07-18T12:47:46-07:00Giảm nhiễm trùng vết mổ trong tái tạo vú bằng implant: Tác động lâm sàng của quy trình GAPS sau 5 năm https://news.medxy.ai/reducing-surgical-site-infection-in-implant-based-breast-reconstruction-clinical-impact-of-the-gaps-protocol-over-five-years/Medxy AIen2026-07-18T12:47:01-07:00Reducing Surgical-Site Infection in Implant-Based Breast Reconstruction: Clinical Impact of the GAPS Protocol over Five Years